An antigenic peptide produced by peptide splicing in the proteasome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15001714.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CD8 T lymphocytes recognize peptides of 8 to 10 amino acids presented by class I molecules of the major histocompatibility complex. Here, CD8 T lymphocytes were found to recognize a nonameric peptide on melanoma cells that comprises two noncontiguous segments of melanocytic glycoprotein gp100(PMEL17). The production of this peptide involves the excision of four amino acids and splicing of the fragments. This process was reproduced in vitro by incubating a precursor peptide of 13 amino acids with highly purified proteasomes. Splicing appears to occur by transpeptidation involving an acyl-enzyme intermediate. Our results reveal an unanticipated aspect of the proteasome function of producing antigenic peptides.
Medical subject headings
- Antigen Presentation
- Cysteine Endopeptidases
- Membrane Glycoproteins
- Multienzyme Complexes
- Neoplasm Proteins
- Peptide Fragments
- Protein Splicing
- T-Lymphocytes, Cytotoxic